Dupilumab Therapy in Nephrotic Syndrome in Children

NCT07091175 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Nephrotic Syndrome in Children
Nephrotic Syndrome Steroid-Dependent

Interventions

BIOLOGICAL: Dupilumab
DRUG: Placebo
DRUG: Co-intervention of Prednisolone wean during randomised controlled phase
BIOLOGICAL: Dupilumab open label extension phase
DRUG: Co-intervention of Prednisolone wean during open label extension phase

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]
[object Object]
[object Object]